These non-transgenic approaches demonstrate the ability to resemble the key mechanisms underlying neurodegeneration in AD [141], including Aβ deposition, tau hyperphosphorylation and neuroinflammation (Table 1). The gene discussed is MAPT; the disease is Alzheimer disease.